Hidehito HORINOUCHI (@hhorinouchi) 's Twitter Profile
Hidehito HORINOUCHI

@hhorinouchi

Medical Oncologist, NCC Japan, Lung Cancer Study Group @JCOG_official, Education committee @JSMO_official @JLCS_OFFICIAL @IASLC @ASCO FCOI bit.ly/3DBhVGE

ID: 149859004

linkhttps://www.linkedin.com/in/hidehito-horinouchi-679b3548/ calendar_today30-05-2010 12:17:24

2,2K Tweet

2,2K Followers

90 Following

Hidehito HORINOUCHI (@hhorinouchi) 's Twitter Profile Photo
Hidehito HORINOUCHI
@hhorinouchi

2 months ago

🔄#ASCO25 REVIEW🔁 ☑️#LCSM Rapid Oral, Mets 🔥LOXO-RAS-20001: Olomorasib + immunotherapy in first-line Tx of pts with KRAS G12C-mutant advanced NSCLC 🎙️ Alex Spira, M.D. 🎯Overall ORR 70%, DCR 90% 🎯PD-L1 ≥50% ORR 82%, DCR 94% OncoAlert ASCO LARVOL meetings.asco.org/2025-asco-annu…

🔄#ASCO25 REVIEW🔁 ☑️#LCSM Rapid Oral, Mets 🔥LOXO-RAS-20001: Olomorasib + immunotherapy in first-line Tx of pts with KRAS G12C-mutant advanced NSCLC 🎙️ <a href="/AlexSpiraMDPhD/">Alex Spira, M.D.</a> 🎯Overall ORR 70%, DCR 90% 🎯PD-L1 ≥50% ORR 82%, DCR 94% <a href="/OncoAlert/">OncoAlert</a> <a href="/ASCO/">ASCO</a> <a href="/Larvol/">LARVOL</a> meetings.asco.org/2025-asco-annu…